MicroRNA expression profile reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer

Medicine (United States)

Volumn 94, Issue 32, 2015, Pages

  Meng, Wen Jian ^a   Yang, Lie ^a   Ma, Qin ^a   Zhang, Hong ^b   Adell, Gunnar ^a   Arbman, Gunnar ^c   Wang, Zi Qiang ^a   Li, Yuan ^a   Zhou, Zong Guang ^a,d   Sun, Xiao Feng ^e   Chen, Xiao Dong ^f  

^a SICHUAN UNIVERSITY   (China)

^b ÖREBRO UNIVERSITY   (Sweden)

^c Department of Clinical Immunology and Transfusion Medicine   (Sweden)

^d VRINNEVI HOSPITAL   (Sweden)

^e LINKÖPING UNIVERSITY   (Sweden)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; MICRORNA; MICRORNA 143; MICRORNA 145; MICRORNA 182; MICRORNA 20A; MICRORNA 92A 1; MICRORNA 92A 2; SMALL NUCLEOLAR RNA; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; UPREGULATION; BIOSYNTHESIS; COLORECTAL TUMOR; GENETICS; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY; PROTEIN MICROARRAY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PROTEIN ARRAY ANALYSIS; RETROSPECTIVE STUDIES; RNA, SMALL NUCLEOLAR;

EID: 84942436314     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001297     Document Type: Article

References (40)

1. Latournerie M, Jooste V, Cottet V, et al. Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg. 2008; 95: 1528-1533.
2. Nosho K, Kure S, Irahara N, et al. A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology. 2009; 137: 1609-1620e1-3.
3. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol. 2011; 223: 102-115.
4. Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008; 299: 425-436.
5. Faltejskova P, Svoboda M, Srutova K, et al. Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med. 2012; 16: 2655-2666.
6. Yan H, Choi AJ, Lee BH, et al. Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells. PLoS One. 2011; 6: e20628.
7. Hamfjord J, Stangeland AM, Hughes T, et al. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One. 2012; 13: e34150.
8. Pacilli A, Ceccarelli C, Treré D, et al. SnoRNA U50 levels are regulated by cell proliferation and rRNA transcription. Int J Mol Sci. 2013; 14: 14923-14935.
9. Galamb O, Spisák S, Sipos F, et al. Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor. Br J Cancer. 2010; 102: 765-773.
10. Lu M, Shi B, Wang J, et al. TAM: a method for enrichment and depletion analysis of a microRNA category in a list of microRNAs. BMC Bioinformatics. 2010; 11: 419.
11. Sun XF p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin Cancer Res. 2002; 8: 165-170.
12. Sun XF, Carstensen JM, Stål O, et al. Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2, p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma. Int J Cancer. 1996; 69: 5-8.
13. Zhang H, Sun XF. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer. Int J Oncol. 2001; 19: 49-52.
14. Zhang H, Sun XF. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol. 2002; 97: 1037-1041.
15. Shen YM, Arbman G, Olsson B, et al. Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis. Int J Biol Markers. 2011; 26: 166-172.
16. Jansson A, Sun XF. Ki-67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas. APMIS. 1997; 105: 730-734.
17. Evertsson S, Bartik Z, Zhang H, et al. Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma. Int J Oncol. 1999; 15: 53-58.
18. Emterling A, Wallin A, Arbman G, et al. Clinicopathological significance of microsatellite instability and mutated RIZ in colorectal cancer. Ann Oncol. 2004; 15: 242-246.
19. Jansson A, Arbman G, Zhang H, et al. Combined deficiency of hMLH1, hMSH2, hMSH3 and hMSH6 is an independent prognostic factor in colorectal cancer. Int J Oncol. 2003; 22: 41-49.
20. Zhang H, Nordenskjöld B, Dufmats M, et al. K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa. Eur J Cancer. 1998; 34: 2053-2057.
21. Pfeifer D, Arbman G, Sun XF. Polymorphism of the p73 gene in relation to colorectal cancer risk and survival. Carcinogenesis. 2005; 26: 103-107.
22. Jansson A, Gentile M, Sun XF. p53 mutations are present in colorectal cancer with cytoplasmic p53 accumulation. Int J Cancer. 2001; 92: 338-341.
23. Zhou XL, Eriksson U, Werelius B, et al. Definition of candidate low risk APC alleles in a Swedish population. Int J Cancer. 2004; 110: 550-557.
24. Zhang H, Arbman G, Sun XF. Codon 201 polymorphism of DCC gene is a prognostic factor in patients with colorectal cancer. Cancer Detect Prev. 2003; 27: 216-221.
25. INK4a, RASSF1A and APC1A genes. Oncol Rep. 2009; 21: 721-729.
26. Babak T, Zhang W, Morris Q, et al. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA. 2004; 10: 1813-1819.
27. Galasso M, Sana ME, Volinia S. Non-coding RNAs: a key to future personalized molecular therapy? Genome Med. 2010; 2: 12.
28. Nicoloso MS, Spizzo R, Shimizu M, et al. MicroRNAs - the microsteering wheel of tumour metastases. Nat Rev Cancer. 2009; 9: 293-302.
29. Pagliuca A, Valvo C, Fabrizi E, et al. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene. 2013; 32: 4806-4813.
30. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA. 2005; 11: 241-247.
31. Bae JM, Cho NY, Kim TY, et al. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors. Dis Colon Rectum. 2012; 55: 181-190.
32. Peltomäki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 1997; 113: 1146-1158.
33. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A. 1998; 95: 6870-6875.
34. Pedroni M, Tamassia MG, Percesepe A, et al. Microsatellite instability in multiple colorectal tumors. Int J Cancer. 1999; 81: 1-5.
35. Abe Y, Masuda H. Genetic alterations of sporadic colorectal cancer with microsatellite instability, especially characteristics of primary multiple colorectal cancers. J Surg Oncol. 2000; 74: 249-256.
36. Lanza G, Ferracin M, Gafà R, et al. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer. 2007; 6: 54.
37. Valeri N, Gasparini P, Fabbri M, et al. Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A. 2010; 107: 6982-6987.
38. Tsafrir D, Bacolod M, Selvanayagam Z, et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res. 2006; 66: 2129-2137.
39. Mannoor K, Liao J, Jiang F. Small nucleolar RNAs in cancer. Biochim Biophys Acta. 2012; 1826: 121-128.
40. Mourtada-Maarabouni M, Pickard MR, Hedge VL, et al. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009; 28: 195-208.